Soleus Capital Management, L.P.

Position in NEO — Neogenomics Inc

CIK 1802630 GREENWICH, CT

Position in NEO

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,298,500

-$3,728,947 QoQ

Shares Held

175,000

-59.1% QoQ

Ownership

0.134%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Soleus Capital Management, L.P. holds $120,978,490 across 6 Diagnostics & Research names. NEO ranks #6 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TWST	Twist Bioscience Corp	1,226,629	$58,289,410
2	NTRA	Natera, Inc.	119,000	$23,798,810
3	ICLR	Icon PLC	192,000	$21,246,720
4	VCYT	Veracyte, Inc.	319,912	$10,304,365
5	BDSX	Biodesix Inc	416,599	$6,040,685
6	NEO	Neogenomics Inc This page	175,000	$1,298,500

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,298,500	175,000	-59.1%	Shares	Sole	2026-05-14
2025-12-31	$5,027,447	427,504	-7.1%	Shares	Sole	2026-02-12
2022-03-31	$5,589,000	460,000	+141.4%	Shares	Sole	2022-05-16
2021-09-30	$9,192,421	190,556	-45.9%	Shares	Sole	2021-11-15
2021-06-30	$15,900,156	352,007	+666.0%	Shares	Sole	2021-08-16
2021-03-31	$2,216,216	45,951	0.0%	Shares	Sole	2021-05-17
2020-12-31	$2,474,001	45,951	—	Shares	Sole	2021-04-29
No filing history on record for this holder in this stock.